Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease

• Published in: Journal of Alzheimer's disease Vol. 42; no. 4; p. 1347
• Main Authors: Alvarez, Antón, Aleixandre, Manuel, Linares, Carlos, Masliah, Eliezer, Moessler, Herbert
• Format: Journal Article
• Language: English
• Published: Netherlands 01.01.2014
• Subjects: Aged; Alzheimer Disease - blood; Alzheimer Disease - genetics; Alzheimer Disease - psychology; Apathy - physiology; Apolipoprotein E4 - genetics; Brain-Derived Neurotrophic Factor - blood; Cognitive Dysfunction - blood; Cognitive Dysfunction - genetics; Cognitive Dysfunction - psychology; Female; Humans; Male; Psychiatric Status Rating Scales; Sex Characteristics; apolipoprotein E ε4 allele; mild cognitive impairment; brain-derived neurotrophic factor; elderly control subjects; serum; Alzheimer's disease; apathy
• ISSN: 1875-8908
• DOI: 10.3233/JAD-140849

Reduced brain-derived neurotrophic factor (BDNF) signaling is considered as a pathogenic event in early Alzheimer's disease (AD), but the influence of apathy and apolipoprotein E ε4 allele (APOE4) on serum BDNF values was not previously investigated in AD. We evaluated serum BDNF levels in AD, amnestic mild cognitive impairment (MCI), and control subjects. Baseline BDNF levels were similar in AD, MCI, and controls. AD patients having apathy showed lower BDNF values than patients without apathy (p < 0.05). After correction for the influence of apathy, APOE4 carriers showed lower BDNF levels (p < 0.01) and MMSE scores (p < 0.01) than non-APOE4 carriers in the subgroup of AD females, but not in males. Significant (p < 0.05) positive correlations between BDNF values and MMSE scores were only observed in subgroups of AD males and of AD patients without apathy. These results are showing the association of apathy and APOE4 with reduced serum BDNF levels in AD, and are suggesting that BDNF reductions might contribute to the worse cognitive performance exhibited by AD apathetic patients and female APOE4 carriers.